EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases.

Duru, N; van der Goes, M C; Jacobs, J W G; Andrews, T; Boers, M; Buttgereit, F; Caeyers, N; Cutolo, M; Halliday, S; Da Silva, J A P; Kirwan, J R; Ray, D; Rovensky, J; Severijns, G; Westhovens, R; Bijlsma, J W J

Duru, N; van der Goes, M C; Jacobs, J W G; Andrews, T; Boers, M; Buttgereit, F; Caeyers, N; Cutolo, M; Halliday, S; Da Silva, J A P; Kirwan, J R; Ray, D; Rovensky, J; Severijns, G; Westhovens, R; Bijlsma, J W J.

Affiliation

Duru N; Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, , Utrecht, The Netherlands.

Ann Rheum Dis ; 72(12): 1905-13, 2013 Dec.

Article in En | MEDLINE | ID: mdl-23873876

Subject(s)

Glucocorticoids/administration & dosage; Glucocorticoids/adverse effects; Rheumatic Diseases/drug therapy; Adrenal Insufficiency/chemically induced; Comorbidity; Delphi Technique; Dose-Response Relationship, Drug; Drug Monitoring/methods; Drug Monitoring/standards; Evidence-Based Medicine/methods; Glucocorticoids/therapeutic use; Humans; Osteoporosis/chemically induced; Osteoporosis/prevention & control; Patient Education as Topic/methods; Practice Guidelines as Topic; Risk Factors

Key words

Autoimmune Diseases; Corticosteroids; Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Rheumatic Diseases / Glucocorticoids Type of study: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Year: 2013 Type: Article

Fulltext

XML

PubMed Links

Search on Google